BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5619-5629
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5619
Table 3 Characteristics of patients with pancreatic cancer according to the international classification of diseases, 10th revision edition
ParametersN (%)C250C251C252C253C254C257C259
Number of patients1846234 (12.7)272 (3.9)104 (5.6)5 (0.3)2 (0.1)1 (0.1)1428 (77.4)
Age at diagnosis65.22 ± 11.97164.72 ± 10.1463.39 ± 10.4865.43 ± 11.3265.20 ± 11.0870.50 ± 4.9545.00 ± 0.0065.39 ± 12.35
Gender (male: Female)1116:730150:8445:2752:521:42:01:0865:563
Diagnostic criteria
Definite910 (49.3)164 (70.1)34 (47.2)45 (43.3)2 (40.0)2 (100.0)1 (100.0)662 (46.4)
Possible936 (50.7)70 (29.9)38 (52.8)59 (56.7)3 (60.0)0 (0.0)0 (0.0)766 (53.6)
Methods of pathologic diagnosis (n = 910)
ERCP or endoscopy163 (17.9)34 (20.7)2 (5.9)8 (17.8)0 (0.0)0 (0.0)0 (0.0)119 (18.0)
EUS-FNA or percutaneous biopsy30 (3.3)4 (2.4)0 (0.0)2 (4.4)0 (0.0)0 (0.0)0 (0.0)26 (3.9)
Surgery717 (78.8)126 (76.8)32 (94.1)35 (77.8)2 (100.0)2 (100.0)1 (100.0)517 (78.1)
CA19-9 > 100 U/L
Yes684 (37.1)95 (40.6)29 (40.3)44 (42.3)1 (20.0)0 (0.0)0 (0.0)515 (36.1)
No514 (27.8)63 (26.9)24 (33.3)23 (22.1)1 (20.0)1 (50.0)0 (0.0)402 (28.2)
Missing648 (35.1)76 (32.5)19 (26.4)37 (35.6)3 (60.0)1 (50.0)1 (100.0)511 (35.8)


Write to the Help Desk